Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
05/12/2009 | US7531352 Inducible plasmid vector encoding TGF-β and use thereof |
05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
05/12/2009 | US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
05/12/2009 | CA2492526C Method for controlling hairballs |
05/12/2009 | CA2454435C Medical adsorbent and process for production of the same |
05/12/2009 | CA2402742C Method of treating or inhibiting colonic polyps |
05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
05/12/2009 | CA2377299C Mesalazine controlled release oral pharmaceutical compositions |
05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
05/07/2009 | WO2009059050A2 Tlr modulators and methods for using the same |
05/07/2009 | WO2009058653A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
05/07/2009 | WO2009058400A1 Compositions for tissue repair/regeneration |
05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
05/07/2009 | WO2009057811A2 Heterocyclic compound and pharmaceutical composition thereof |
05/07/2009 | WO2009057796A1 Laxative agent |
05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
05/07/2009 | WO2009057165A1 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
05/07/2009 | WO2009055867A1 Treatment of metabolic disease |
05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
05/07/2009 | US20090118353 Medicinal composition |
05/07/2009 | US20090118350 Biomarkers for Identifying Efficacy of Tegaserod in Patients with Chronic Constipation |
05/07/2009 | US20090118342 Design and synthesis of biotinylated probes for n-acyl-ethanolamines |
05/07/2009 | US20090118335 Acid Secretion Inhibitor |
05/07/2009 | US20090118330 Diurea derivatives |
05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
05/07/2009 | US20090118327 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
05/07/2009 | US20090118314 Tumor suppressor |
05/07/2009 | US20090118307 Aryl Sulfonamides |
05/07/2009 | US20090118302 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses |
05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
05/07/2009 | US20090118266 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
05/07/2009 | US20090118238 Deuterium-enriched alendronate |
05/07/2009 | US20090118225 1-Methyl Nicotinamide and Derivatives for Treatment of Gastric Injury |
05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
05/07/2009 | US20090118179 topically administering a fibroblast growth factor; treating a tooth with a dental parenchyma loss due to dental caries, tooth attrition or injury; promoting cell proliferation and differentiation; dentistry |
05/07/2009 | US20090118173 Treatment and prevention of inflammatory bowel diseases |
05/07/2009 | US20090118170 Buccal, polar and non-polar spray or capsule |
05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
05/07/2009 | US20090117209 Andrographis paniculata extract |
05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
05/07/2009 | US20090117146 System and method for promoting hair growth and improving hair and scalp health |
05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
05/07/2009 | US20090117092 Collagenolytic active enzyme containing compositions, and their use in the dental field |
05/07/2009 | US20090117064 Stable vitamin b6 derivative |
05/07/2009 | US20090117056 Probiotic oral dosage forms |
05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
05/07/2009 | DE102007052870A1 Verwendung von Polyethylenglykol-Pulvern und Zusammensetzungen enthaltend diese Use of polyethylene glycol and compositions comprising these powders |
05/07/2009 | CA2704627A1 Compositions for tissue repair/regeneration |
05/07/2009 | CA2704185A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
05/07/2009 | CA2703240A1 Heterocyclic compound and pharmaceutical composition thereof |
05/07/2009 | CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
05/06/2009 | EP2054429A2 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
05/06/2009 | EP2054066A2 Methods for treatment of radiation enteritis |
05/06/2009 | EP1537206B1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
05/06/2009 | EP1443961B1 Glycoprotein compositions |
05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
05/06/2009 | EP1089724B1 Cyano substituted oleanolic acid derivatives as no production inhibitors |
05/06/2009 | EP0935417B1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
05/06/2009 | CN101426528A Methods of using antibodies against human IL-22 |
05/06/2009 | CN101426501A The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
05/06/2009 | CN101426491A GIP secretion inhibitor |
05/06/2009 | CN101426484A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
05/06/2009 | CN101423811A Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
05/06/2009 | CN101423555A Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
05/06/2009 | CN101423554A Antivariant streptococcus polypeptide and use thereof and preparation method |
05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
05/06/2009 | CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
05/06/2009 | CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
05/06/2009 | CN101422609A Use of lentinan as hepatic C virus nucleic acid vaccine immunologic adjavant |
05/06/2009 | CN101422595A Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof |
05/06/2009 | CN101422590A Medicine for treating toothache and preparation method thereof |